Angiotensin-(1-7) in Paraventricular Nucleus Modulates Sympathetic Activity and Cardiac Sympathetic Afferent Reflex in Renovascular Hypertensive Rats

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Han, Ying ^a   Sun, Hai Jian ^a   Li, Peng ^a   Gao, Qing ^a   Zhou, Ye bo ^a   Zhang, Feng ^a   Gao, Xing Ya ^a   Zhu, Guo Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CAPSAICIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MAS RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC SYMPATHETIC AFFERENT REFLEX; CONTROLLED STUDY; MALE; MEAN ARTERIAL PRESSURE; NEUROMODULATION; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PROTEIN EXPRESSION; RAT; RENAL SYMPATHETIC NERVE ACTIVITY; RENOVASCULAR HYPERTENSION; SYMPATHETIC REFLEX; SYMPATHETIC TONE;

ADENINE; AFFERENT PATHWAYS; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; BUCLADESINE; CYCLIC AMP; HEART; HYPERTENSION, RENOVASCULAR; KIDNEY; MALE; MICROINJECTIONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; REFLEX; SYMPATHETIC NERVOUS SYSTEM; THIONUCLEOTIDES;

RATTUS;

EID: 84868355106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048966     Document Type: Article

References (53)

1. Hogarth AJ, Mackintosh AF, Mary DA, (2007) The effect of gender on the sympathetic nerve hyperactivity of essential hypertension. J Hum Hypertens 21: 239-245.
2. Biaggioni I, (2008) Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? Hypertension 51: 168-171.
3. Rubinger D, Backenroth R, Sapoznikov D, (2012) Sympathetic Activation and Baroreflex Function during Intradialytic Hypertensive Episodes. PLoS One 7: e36943.
4. Ramchandra R, Watson AM, Hood SG, May CN, (2010) The response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure. Am J Physiol Regul Integr Comp Physiol 298: R1056-R1060.
5. Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, et al. (2007) Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49: 506-510.
6. Han Y, Fan ZD, Yuan N, Xie GQ, Gao J, et al. (2011) Superoxide anions in paraventricular nucleus mediate the enhanced cardiac sympathetic afferent reflex and sympathetic activity in renovascular hypertensive rats. J Appl Physiol 110: 646-652.
7. Fujita M, Ando K, Nagae A, Fujita T, (2007) Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50: 360-367.
8. Stocker SD, Meador R, Adams JM, (2007) Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension 49: 640-646.
9. Marques FZ, Campain AE, Davern PJ, Yang YH, Head GA, et al. (2011) Genes influencing circadian differences in blood pressure in hypertensive mice. PLoS One 6: e19203.
10. Fan ZD, Zhang L, Shi Z, Gan XB, Gao XY, et al. (2012) Artificial microRNA interference targeting AT1a receptors in paraventricular nucleus attenuates hypertension in rats. Gene Ther 19: 810-817.
11. Mancia G, Grassi G, Giannattasio C, Seravalle G, (1999) Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34: 724-728.
12. Morise T, Horita M, Kitagawa I, Shinzato R, Hoshiba Y, et al. (2000) The potent role of increased sympathetic tone in pathogenesis of essential hypertension with neurovascular compression. J Hum Hypertens 14: 807-811.
13. Rahn KH, Barenbrock M, Hausberg M (1999) The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens Suppl 17: S11-S14.
14. Del CS, Morello F, Rabbia F, Milan A, Naso D, et al. (2007) Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 50: 487-496.
15. Fisher JP, Fadel PJ, (2010) Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol 95: 572-580.
16. Grassi G, Seravalle G, Quarti-Trevano F, (2010) The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95: 581-586.
17. Du YH, Chen AF, (2007) A "love triangle" elicited by electrochemistry: complex interactions among cardiac sympathetic afferent, chemo-, and baroreflexes. J Appl Physiol 102: 9-10.
18. Malliani A, Montano N, (2002) Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension 39: 63-68.
19. Han Y, Yuan N, Zhang SJ, Gao J, Shi Z, et al. (2011) c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats. Pflugers Arch 461: 437-446.
20. Zhu GQ, Xu Y, Zhou LM, Li YH, Fan LM, et al. (2009) Enhanced cardiac sympathetic afferent reflex involved in sympathetic overactivity in renovascular hypertensive rats. Exp Physiol 94: 785-794.
21. Chen AD, Zhang SJ, Yuan N, Xu Y, De W, et al. (2011) AT1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats. Exp Physiol 96: 94-103.
22. Zhong MK, Duan YC, Chen AD, Xu B, Gao XY, et al. (2008) Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol 93: 746-753.
23. Badoer E, (2001) Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 28: 95-99.
24. Xu P, Sriramula S, Lazartigues E, (2011) ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 300: R804-R817.
25. Santos RA, Haibara AS, Campagnole-Santos MJ, Simoes e Silva AC, Paula RD, et al. (2003) Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7). Hypertension 41: 737-743.
26. Block CH, Santos RA, Brosnihan KB, Ferrario CM, (1988) Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides 9: 1395-1401.
27. Krob HA, Vinsant SL, Ferrario CM, Friedman DP, (1998) Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat. Brain Res 798: 36-45.
28. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM, (1989) Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 264: 16518-16523.
29. Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, et al. (1995) Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 357: 27-32.
30. Silva AQ, Santos RA, Fontes MA, (2005) Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension 46: 341-348.
31. Gironacci MM, Brosnihan KB, Ferrario CM, Gorzalczany S, Verrilli MA, et al. (2007) Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension. Peptides 28: 1580-1585.
32. Liu GC, Oudit GY, Fang F, Zhou J, Scholey JW, (2012) Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am J Physiol Renal Physiol 302: F784-F790.
33. Tallant EA, Clark MA, (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42: 574-579.
34. Gan XB, Duan YC, Xiong XQ, Li P, Cui BP, et al. (2011) Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure. PLoS ONE 6: e25784.
35. Zhang L, Xiong XQ, Fan ZD, Gan XB, Gao XY, et al. (2012) Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes. J Appl Physiol 113: 47-55.
36. Becker LK, Etelvino GM, Walther T, Santos RA, Campagnole-Santos MJ, (2007) Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 293: H1416-H1424.
37. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD, (2010) Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 298: F1523-F1532.
38. Huentelman MJ, Zubcevic J, Katovich MJ, Raizada MK, (2004) Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul Pept 122: 61-67.
39. Xia H, Suda S, Bindom S, Feng Y, Gurley SB, et al. (2011) ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One 6: e22682.
40. Yamazato M, Ferreira AJ, Yamazato Y, ez-Freire C, Yuan L, et al. (2011) Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats. J Renin Angiotensin Aldosterone Syst 12: 456-461.
41. Zhou LM, Shi Z, Gao J, Han Y, Yuan N, et al. (2010) Angiotensin-(1-7) and angiotensin II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats. Pflugers Arch 459: 681-688.
42. Felix D, Khosla MC, Barnes KL, Imboden H, Montani B, et al. (1991) Neurophysiological responses to angiotensin-(1-7). Hypertension 17: 1111-1114.
43. Ambuhl P, Felix D, Khosla MC, (1994) [7-D-ALA]-angiotensin-(1-7): selective antagonism of angiotensin-(1-7) in the rat paraventricular nucleus. Brain Res Bull 35: 289-291.
44. Capettini LS, Montecucco F, Mach F, Stergiopulos N, Santos RA, et al. (2012) Role of Renin-Angiotensin system in inflammation, immunity and aging. Curr Pharm Des 18: 963-970.
45. Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC, (2012) Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol (302) (): R518-R530.
46. Zhang F, Hu Y, Xu Q, Ye S, (2010) Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS One 5: e12323.
47. Nakagaki T, Hirooka Y, Ito K, Kishi T, Hoka S, et al. (2011) Role of angiotensin-(1-7) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats. Clin Exp Hypertens 33: 223-230.
48. Zimmerman MC, (2011) Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system. Curr Opin Pharmacol 11: 138-143.
49. Rossi NF, Maliszewska-Scislo M, Chen H, Black SM, Sharma S, et al. (2010) Neuronal nitric oxide synthase within paraventricular nucleus: blood pressure and baroreflex in two-kidney, one-clip hypertensive rats. Exp Physiol 95: 845-857.
50. Li YF, Wang W, Mayhan WG, Patel KP, (2006) Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Integr Comp Physiol 290: R1035-R1043.
51. Li YF, Patel KP, (2003) Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand 177: 17-26.
52. Campese VM, Ye S, Zhong H, (2002) Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 39: 519-524.
53. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100: 8258-8263.